CITADEL ADVISORS LLC

Position in INM — InMed Pharmaceuticals Inc.

CIK 1423053 MIAMI, FL

Position in INM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,297

+$16,868 QoQ

Shares Held

46,973

-17.1% QoQ

Ownership

1.42%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $927,090,430 across 59 Drug Manufacturers - Specialty & Generic names. INM ranks #54 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	360,643	$213,854,086
2	INDV	Indivior Pharmaceuticals, Inc.	3,574,044	$108,936,860
3	ELAN	Elanco Animal Health Inc	4,387,127	$104,983,948
4	ALKS	Alkermes plc.	2,241,584	$79,262,409
5	SUPN	Supernus Pharmaceuticals, Inc.	1,493,446	$77,196,223
6	ZTS	Zoetis Inc.	501,011	$59,224,510
7	VTRS	Viatris Inc	3,993,155	$53,947,523
8	KNSA	Kiniksa Pharmaceuticals International, plc	474,750	$22,859,212

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,297	46,973	-17.1%	Shares	Defined	2026-05-15
2024-09-30	$13,429	56,666	+368.4%	Shares	Defined	2024-11-14
2024-06-30	$3,217	12,097	-4.9%	Shares	Defined	2024-08-14
2024-03-31	$4,631	12,725	-62.6%	Shares	Defined	2024-05-15
2023-12-31	$14,147	34,009	+162.3%	Shares	Defined	2024-02-14
2022-06-30	$6,094	12,966	+17.2%	Shares	Defined	2022-08-15
2021-12-31	$14,488	11,060	-38.4%	Shares	Defined	2022-02-14
2021-09-30	$31,398	17,942	+17.2%	Shares	Defined	2021-11-15
2021-06-30	$48,685	15,310	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.